# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 481-490 of 562 results.
Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
Status: Recruiting
Last Changed: Jul 30, 2020
First Received: Jul 23, 2019
Disease(s): Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory, Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Small Lymphocytic Lymphoma
Intervention(s): PBCAR20A, Fludarabine, Cyclophosphamide
Locations: City of Hope, Duarte, California, United States
Stanford University, Stanford, California, United States
Columbia University, New York, New York, United States
Cleveland Clinic, Cleveland, Ohio, United States
MD Anderson Cancer Center, Houston, Texas, United States
... and 1 other locations.
A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Mar 13, 2017
Disease(s): Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma, Mucosal-Associated Lymphoid Tissue Lymphoma
Intervention(s): Vitamin D, Rituximab, Placebo
Locations: University of Miami, Miami, Florida, United States
Emory University, Winship Cancer Institute, Atlanta, Georgia, United States
University of Iowa, Iowa City, Iowa, United States
Washington University, Saint Louis, Missouri, United States
Weill Cornell Medical College, New York, New York, United States
... and 3 other locations.
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma
Status: Not yet recruiting
Last Changed: Apr 24, 2020
First Received: Jan 10, 2020
Disease(s): Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma
Intervention(s): CAR.k.28, Fludarabine, Cyclophosphamide, Bendamustine
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina, United States
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Status: Recruiting
Last Changed: Mar 11, 2020
First Received: Apr 19, 2019
Disease(s): Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Follicular, Lymphoma, Peripheral T-Cell, Lymphoma, Hodgkin
Intervention(s): OT-82 Dose Escalation, OT-82 Dose Expansion
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
City of Hope National Medical Center, Duarte, California, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
... and 1 other locations.
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
Status: Recruiting
Last Changed: Jul 07, 2020
First Received: Oct 07, 2016
Disease(s): Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
Intervention(s): Ibrutinib, Radiation Therapy, TLR9 Agonist SD-101
Locations: Stanford University, School of Medicine, Palo Alto, California, United States
Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies
Status: Recruiting
Last Changed: Mar 03, 2020
First Received: Nov 14, 2014
Disease(s): Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Intervention(s): REGN1979 multiple dose levels, Rituximab
Locations: University of California, Irvine, Orange, California, United States
Stanford University, Stanford, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Dana Farber Cancer Institute (Massachusetts General Hospital and Beth Israel), Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
... and 5 other locations.
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Status: Recruiting
Last Changed: Mar 17, 2020
First Received: Nov 07, 2017
Disease(s): Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Aplastic Anemia, B-Cell Non-Hodgkin Lymphoma, CD40 Ligand Deficiency, Chronic Granulomatous Disease, Chronic Leukemia in Remission, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Congenital Amegakaryocytic Thrombocytopenia, Congenital Neutropenia, Congenital Pure Red Cell Aplasia, Glanzmann Thrombasthenia, Immunodeficiency Syndrome, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Paroxysmal Nocturnal Hemoglobinuria, Plasma Cell Myeloma, Polycythemia Vera, Recurrent Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndrome, Severe Aplastic Anemia, Shwachman-Diamond Syndrome, Sickle Cell Disease, T-Cell Non-Hodgkin Lymphoma, Thalassemia, Waldenstrom Macroglobulinemia, Wiskott-Aldrich Syndrome
Intervention(s): Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis, Peripheral Blood Stem Cell Transplantation, Total-Body Irradiation
Locations: Roswell Park Cancer Institute, Buffalo, New York, United States
DS-3201b in Participants With Lymphomas
Status: Recruiting
Last Changed: May 13, 2020
First Received: Apr 08, 2016
Disease(s): Lymphoma, Malignant, Non-hodgkin Lymphoma
Intervention(s): DS-3201b
Locations: Yale University, New Haven, Connecticut, United States
Emory University, Atlanta, Georgia, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
... and 11 other locations.
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Status: Recruiting
Last Changed: Dec 26, 2018
First Received: Dec 26, 2018
Disease(s): Cancer, Breast Cancer, Gastric Cancer, Renal Cancer, Prostate Cancer, Melanoma, Lung Cancer, Hepatocellular Cancer, Colorectal Cancer, Head and Neck Cancer, Pancreatic Cancer, Ovarian Cancer, Glioblastoma, Endometrial Cancer, Bladder Cancer, Esophageal Cancer, B-cell Lymphoma
Intervention(s): Blood draws
Locations: Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST, Bron, France
Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse, Lyon, France
Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot, Lyon, France
Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse, Lyon, France
Service d'Urologie de l'Hôpital E. Herriot, Lyon, France
... and 13 other locations.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Status: Recruiting
Last Changed: Jul 22, 2020
First Received: Jun 18, 2009
Disease(s): Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma, Monoclonal B-Cell Lymphocytosis, Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia)
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States